Manager × security

DAFNA Capital Management LLC RVMD holdings history

Who else holds this security? →

REVOLUTION MEDICINES INC · CUSIP 76155X100 · CIK 1389933

This is the oldest quarter open without an account, so changes against the quarter before it are withheld. Sign in to see them.
Citable facts

As of 2026-06-30, DAFNA Capital Management LLC reported 562.63K RVMD (shares), valued at $105.37M, or 20.09% of its reported non-derivative portfolio. Filed 2026-08-14.

Verify history & sources →
Portfolio weight and quantity history
Reported portfolio weight
20.09%
Shares
562.63K
562,630
Reported value
$105.37M
USD

Shares decreased 3.11%; reported value increased 86.59%, and weight changed +7.24 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.

Left: % · Right: Shares · Independently scaled axes

Exact data and methodology

Axes scale independently; a crossing does not mean equal values. Weight uses each quarter's total reported non-derivative value. Same CUSIP; missing quarters are gaps, not zero. Revised history may include later disclosures.

QuarterWeightQuantitySource
Q2 202620.09%562,630SEC filing ↗Filed Aug 14, 2026
Q1 202612.85%580,678SEC filing ↗Filed May 15, 2026
Q4 202511.18%604,514SEC filing ↗Filed Feb 17, 2026
Q3 20257.58%657,176SEC filing ↗Filed Nov 14, 2025
Q2 20256.88%677,176SEC filing ↗Filed Aug 14, 2025
Q1 20256.58%656,176SEC filing ↗Filed May 15, 2025
Q4 20247.02%631,176SEC filing ↗Filed Feb 14, 2025
Q3 20245.55%517,994SEC filing ↗Filed Nov 14, 2024
Q2 20244.75%511,894SEC filing ↗Filed Aug 14, 2024
Q1 20243.76%511,894SEC filing ↗Filed May 15, 2024
Q4 20233.52%511,894SEC filing ↗Filed Feb 14, 2024
Q3 20234.08%473,394SEC filing ↗Filed Nov 14, 2023

History & evidence by quarter

QuarterWeightQuantityValueChange explainedSource
Q3 20234.08%473,394$13.10MThe prior quarter is outside the free window. Sign in for the comparison.SEC filing ↗
Filed Nov 14, 2023
Q4 20233.52%511,894$14.68MShares increased 8.13%; reported value increased 12.04%, and weight changed -0.56 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.SEC filing ↗
Filed Feb 14, 2024
Q1 20243.76%511,894$16.50MShares unchanged; reported value increased 12.38%, and weight changed +0.24 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.SEC filing ↗
Filed May 15, 2024
Q2 20244.75%511,894$19.87MShares unchanged; reported value increased 20.42%, and weight changed +0.99 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.SEC filing ↗
Filed Aug 14, 2024
Q3 20245.55%517,994$23.49MShares increased 1.19%; reported value increased 18.24%, and weight changed +0.80 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.SEC filing ↗
Filed Nov 14, 2024
Q4 20247.02%631,176$27.61MShares increased 21.85%; reported value increased 17.52%, and weight changed +1.47 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.SEC filing ↗
Filed Feb 14, 2025
Q1 20256.58%656,176$23.20MShares increased 3.96%; reported value decreased 15.96%, and weight changed -0.44 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.SEC filing ↗
Filed May 15, 2025
Q2 20256.88%677,176$24.91MShares increased 3.20%; reported value increased 7.37%, and weight changed +0.30 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.SEC filing ↗
Filed Aug 14, 2025
Q3 20257.58%657,176$30.69MShares decreased 2.95%; reported value increased 23.19%, and weight changed +0.70 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.SEC filing ↗
Filed Nov 14, 2025
Q4 202511.18%604,514$48.15MShares decreased 8.01%; reported value increased 56.89%, and weight changed +3.60 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.SEC filing ↗
Filed Feb 17, 2026
Q1 202612.85%580,678$56.47MShares decreased 3.94%; reported value increased 17.28%, and weight changed +1.67 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.SEC filing ↗
Filed May 15, 2026
Q2 202620.09%562,630$105.37MShares decreased 3.11%; reported value increased 86.59%, and weight changed +7.24 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.SEC filing ↗
Filed Aug 14, 2026
DAFNA Capital Management LLC · REVOLUTION MEDICINES INC

Take these holdings further.

This page includes 12 of 12 reported holdings. Sign in to look up the full history beyond 3 years, use advanced screening & filtering, download CSV, and get the complete set through the Akkru API.

  • Download CSV
  • Earlier quarters
  • Advanced screening & filtering
  • API & AI access
Already have an account?

+ New accounts get free API credits to explore data beyond ownership filings.

For AI agents & developers

The initial HTML of this page carries its exact data as script#research-data (JSON): values, units, scope, preview limits and SEC sources. Read it directly, no script or API key needed; script#research-access says what needs an account.

Without an account: the last 3 years, with the row caps stated on the page. A free account opens all history on file on these pages and the CSV of what a page shows. Rows beyond the caps and bulk retrieval go through the authenticated API / MCP.

MCP  https://api.akkrudata.ai/mcp

get_institutional_portfolio
{"cik":"1389933","quarter":"2026Q2","cusip":"76155X100"}

get_institutional_manager_history
{"cik":"1389933","page_size":100}

Connect to MCP with OAuth and follow the returned pagination. Credits and usage limits depend on the account.

MCP endpoint
https://api.akkrudata.ai/mcp
API / MCP documentation
/documents
llms.txt
/llms.txt
Sources, coverage & how to read this data

Figures are as reported to the SEC and merged with later amendments where Akkru could match them. Preview limits apply to what is listed, not to the totals, which come from the complete reported data. Nothing is zero-filled: a missing quarter or month is shown as missing.

13F reports quarter-end long positions in securities traded on US exchanges, filed by managers holding at least $100 million of such securities; it is not the manager's full portfolio, not assets under management, and value changes are not returns. Weights use the reported total value as denominator. Option rows show notional value, not premium or net exposure. Amendments are merged into the quarter when Akkru could match them.